Semax 10mg Atomised Solution

Semax 10mg Atomised Research Solution

Semax 10mg is supplied in an atomised research solution by Alpha Peptides® for laboratory and in vitro investigation. Supplied from the UK, with UK-only delivery.

For the separate research-peptide listing, view our Semax 10mg research peptide.

The compound is investigated in experimental models relating to ACTH-fragment-associated signalling, neurotrophin-associated pathways and wider neuronal communication.

Published investigations remain experimental and do not establish suitability, safety or effectiveness for human or veterinary use.

The atomised format describes the product presentation only and does not indicate suitability for human or veterinary administration.

Reading the atomised-solution specification

The 10mg designation states compound content; it does not, by itself, state liquid volume or concentration. Check the current product label for the solution specification. The separately listed research material has its own presentation and should be assessed independently.

For background, an original Semax study in rat glial cell cultures examined NGF and BDNF gene expression. That laboratory study does not test this atomised formulation or establish its equivalence to the material used by the researchers.

Review available product and batch documentation. Coverage varies; check that the record matches the material you are considering.

---

Research Areas

• ACTH-fragment-associated research
• Neuropeptide-signalling studies
• Neurotrophin-associated pathways
• Neuronal-communication research
• Preclinical neurobiology models

---

Product Information

• Compound content: 10mg
• Format: Atomised research solution

---

Important Research Use Notice

This product is supplied strictly for laboratory and in vitro research purposes only.
Not for human consumption.
Not for veterinary use.
Not for medical, therapeutic, diagnostic or administration purposes.